Interview with Daniel J. Wallace, MD, FAAP, FACR
How has Dubois’ Lupus Erythematosus and Related Syndromes, 10th Edition evolved since the previous edition? How has it evolved since the first edition?
The 10th edition represents my 8th revision since the original Dubois’ Lupus Erythematosus came out in 1966. It is 4 times as long, no longer written by a single individual and much more comprehensive.
What is the most exciting aspect of Dubois’ Lupus Erythematosus and Related Syndromes, 10th Edition? What chapter or topic covered in the new edition are you most excited about?
The 10th edition has 3 new associate editors, half of the authors are women, they come from 5 continents, and half of the authors are new. The new edition focuses on several heretofore under-covered areas: Recently approved drugs for autoimmune disorders, newly published insights into the causes and pathogenesis of the disease, and epidemiologic factors that involve diversity and inclusivity and access to care.
Who will find the greatest value from Dubois’ Lupus Erythematosus and Related Syndromes, 10th Edition and why? Has the audience changed since the book was first published?
The book is intended for physicians, basic scientists and immunologists, rheumatologists, and allied health professionals.
What new ideas, practices, or procedures would you like to highlight for Dubois’ Lupus Erythematosus and Related Syndromes, 10th Edition?
The book will be able to have selected chapters updated and available for purchase.
What problem do you hope the future generation of your specialty will be able to solve?
Future rheumatologists will focus on newer procedures (e.g., bedside ultrasound), providing multidisciplinary care in a health care system, artificial intelligence, and improved delivery systems for educational and medical care.
About the Author
My name is Daniel J. Wallace, M.D. By way of background, I am board-certified in Internal Medicine and Rheumatology and licensed to practice in the State of California. I graduated from the University of Southern California School of Medicine in 1974, completed a medical internship at Brown University finishing in 1975, a medical residency at Cedars-Sinai Medical Center, and a rheumatology fellowship at UCLA School of Medicine finishing in 1979. My publications and experience include over 450 peer review publications, 8 rheumatology textbooks (including three on fibromyalgia), 30 book chapters, as well as numerous National Institutes of Health and Department of Defense grants. I am currently a Professor of Medicine at Cedars-Sinai Medical Center and the David Geffen School of Medicine at UCLA, Co-Director of the Rheumatology Fellowship Program at Cedars-Sinai, and serve on their Board of Governors. I also see patients with fellows at Cedars-Sinai at their Lupus and Sjogren’s clinics, founded Lupus LA, and am currently on the national boards of the Lupus Research Alliance, Sjogren’s Foundation, and Lupus Therapeutics. I have also served on the Board of Directors of the Scleroderma Foundation.
Purchase your copy of Dubois’ Lupus Erythematosus and Related Syndromes, 10th Edition here!
Leave A Comment